Approved for Treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial regimen in adults who have limited or no alternative treatment options. Amikacin liposome inhalation suspension delivers amikacin directly to the lungs via nebulization. The liposomal formulation provides sustained release of amikacin, an aminoglycoside that inhibits… Side effects,…
Loading full data from Know Your Drugs Institute…